Moreover, it reduced phospho-BAD expression, exhibited no treatment toxicity and reduced tumor volume.49,50 This pattern of selectivity is often replicated by other PIM inhibitors, as many of them inhibit PIM2 much less efficiently than other PIM kinases.51 This evidence concerns the gene PIM1 and neoplasm.